After an FDA rejection of its spinocerebellar ataxia (SCA) therapy, Biohaven was forced to rethink its strategy—cutting R&D spend by 60% and channeling the spirit of a scrappy startup again as it ...

Two law professors outline strategies for equality’s survival in a Trumpian post-DEI era in new book How Equality Wins ...

Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...

FDA issues a surprise refusal to review Moderna's mRNA-based flu vaccine filing, despite earlier agreement on trial design.

When structure comes first, with clear workflows, disciplined governance and transparent measurement, change becomes repeatable instead of reactive.

Q4 2025 Earnings Call February 17, 2026 7:01 PM ESTCompany ParticipantsKevin Gallagher - MD, CEO & DirectorLachlan Harris - ...

AI-driven automation threatens HCM's revenue model; leading industry players are down 28% to 47% YTD in 2026. Read the full ...

A Florida campaign hasn’t thrown in the towel just yet on its proposal to put marijuana legalization on the November ballot, ...

Triple Flag Precious Metals Corp. (with its subsidiaries, "Triple Flag" or the "Company") (TSX: TFPM, NYSE: TFPM) announced its results for the fourth quarter and full year of 2025 and declared a ...

First in a three-part series. As a laser burned away the hair on her leg, Samar El Hussein felt searing pain. An electrologist at The Refinery Medspa in West Melbourne assured her the work was ...

Company Announcement no. 03/2026 cBrain delivers a solid EBT margin of 22% and increases dividends by 56% Copenhagen, February 19, 2026 cBrain is paving the way for a new type of enterprise software ...